CBIO EPS Estimates - Crescent Biopharma, Inc. logo

CBIO EPS Estimates

Crescent Biopharma, Inc.

$13.04
-$0.46(-3.41%)
36
Overall
40
Value
40
Tech
28
Quality
How is this score calculated?
Market Cap
$507.20M
Volume
214.59K
52W Range
$8.72 - $27.41
Target Price
$32.71

CBIO EPS estimates: the consensus estimate for Crescent Biopharma, Inc.'s current fiscal year is -$2.93 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

CBIO EPS Estimates

EPS estimate, current quarter
$-0.75
EPS estimate, next quarter
$-0.86
EPS estimate, current year
$-2.93
EPS estimate, next year
$-3.17
EPS growth, 3-year
+47.59%
CBIO reported EPS by year
Fiscal yearEPS
2025$-12.81
2024$-0.59
2023$-58.00
2022$-89.00
2021$-123.00
ABCD
1SymbolPriceChangeVol
2CBIO$13.04-3.4%214.59K
3
4
5
6

Get Crescent Biopharma, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.